A clear focus on CNS and Hospital Care

Ethypharm is a specialty pharmaceutical company with products for Central Nervous System (CNS) indications, notably severe pain, and opioid dependency as well as a wide range of injectable medicines for hospitals and emergency situations.

To continue on our transformation journey and accelerate our growth, we have identified specific CNS diseases and conditions and critical care situations where our skills and know-how can be leveraged to bring innovations to patients and health care providers.

Our teams and resources are fully focused on making these opportunities happen.

Join our international mission-driven Team!   

We are a multi-disciplinary, international team, composed of various personalities who join through common values and collective thinking.   
We are convinced that our diversity and the combination of our talents are our strength.

The Group is led by a management team with a broad range of expertise in the pharmaceutical industry.

An entrepreneurial mindset and shared values unite us in achieving our vision for the Group.

Discover our Management Team

A solid and growing presence in our core geographies

Since 2015, Ethypharm has built its direct commercial presence in Europe and China.

In Europe, Ethypharm is present in the 5 largest markets – Germany, France, Italy, the United Kingdom, and Spain. Direct sales account for 49% of pharma sales. We are actively working on scaling our presence in these five countries.

In China, Ethypharm is one among the few European specialty pharmaceutical companies to have a longstanding direct presence. This great asset is being leveraged via partnerships.

In the rest of the world, we rely on our network of distributors and licensees to establish and develop the reach of our product portfolio.